H. Selye, The Stress of Life (New York: McGraw Hill, 1978.
T.H. Holmes and R.H. Rahe. "The Social Readjustment Scale", J Psychosomatic Res 11 (1967): 213-8.
H. Benson, The Relaxtion Response (New York: William Morrow, 1975).
T. Clou, "Wake up and smell the Coffee: Caffeine, Coffee, and the medical Consequenses", West J Med 157 (1992): 544-53.
Levi L. The effect of coffee on the function of the sympathoadrenomedullary system in man. Acta Med Scand 181:431-8, 1967; Robertson D, Frølich JC, Carr RK, et al. Effects of caffeine on plasma activity, catecholamines and blood pressure. N Engl J Med 298:181-6, 1978.
Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 327-1109-14, 1992.
Hughes JR et al. Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. Arch Gen Psychiatry 48:611-17, 1991.
Bruce M, Lader M. Caffeine abstention in the management of anxiety disorders.
Psychol Med 19:211-14, 1989.
Lee MA et al. Anxiety and caffeine consumption in people with anxiety disorders. Psychiatry Res 15:211-17, 1985.
Charney DS et al. Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42:233-43, 1985.
Uhde TW et al. Caffeine and behavior: Relation to psychopathology and underlying mechanisms. Caffeine: Relationship to human anxiety, plasma MHPG and cortisol. Psychopharm Bull
20(3):426-30, 1984.
Boulenger JP et al. Increased sensitivity to caffeine in patients with panic disorders: Preliminary evidence. Arch Gen Psychiatry 41:1067-71, 1984.
Lee MA et al. Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 145(5):632-5, 1988.
A. Winokur et al. "Insulin Resistance after Glukose Tolerance Testing in Patients with Major Depression". Am J Psychiatry 145 (1988): 325-30.
J.H. Wright et al., "Glucose Metabolism in Unipolar Depression", Br J Psychiatry 132 (1978): 386-93.
S. Shibata et al., "Chemistry and Pharmacology og Panax", Econ Med Plant Research 1 (1985): 217-84.
Roelofs SM. Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 2(3):501-5, 1985.
Monteiro MG et al. Subjective feelings of anxiety in young men after ethanol and diazepam infusions. J Clin Psychiatry 51(1):12-16, 1990.
Rainey JM Jr et al. Specificity of lactate infusion as a model of anxiety. Psychopharmacol Bull 20(1):45-9, 1984.
Wendel OW, Beebe WE. Glycolytic activity in schizophrenia, in D Hawkins, L Pauling, Eds. Orthomolecular Psychiatry: Treatment of Schizophrenia. San Francisco, W. H. Freeman, 1973.
Abbey LC. Agoraphobia. J Orthomol Psychiatry 11:243-59, 1982.
Gaby AR. Vitamin B3 (Part 2): Powerful tool in nutritional medicine. Nutrition & Healing, December, 1995.
Kennedy B et al. Similarity between the action of nicotinamide and diazepam on neurotransmitter metabolism in the rat. Biochem Soc Trans 8(1):59, 1980.
Möhler H et al. Nicotinamide is a brain constituent with benzodiazepine-like actions. Nature 278:563-5, 1979.
Heseker H, Kübler W, Pudel V, Westenhöffer J. Psychological disorders as early symptoms of a mild-moderate vitamin deficiency. Ann N Y Acad Sci 669:352-7, 1992.
Hoes MJ et al. Hyperventilation syndrome, treatment with L-tryptophan and pyridoxine; Predictive value of xanthurenic acid excretion. J Orthomol Psychiatry 10(1):7-15, 1981.
Carlson RJ. Longitudinal observations of two cases of organic anxiety syndrome. Psychosomatics 27(7):529-31, 1986.
Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990.
Weston PG et al. Magnesium sulphate as a sedative. Am J Med Sci 165:431-3, 1923.
August F. Daro, professor emeritus, Stritch School of Medicine, Maywood, Illinois, 1981.
McCleane GJ, Watters CH. Pre-operative anxiety and serum potassium. Anaesthesia 45(7):583-5, 1990.
Benton D, Cook R. The impact of selenium supplementation on mood. Biol Psychiatry
29:1092-8, 1991.
Kahn RS, Westenberg HG. L-5- hydroxytryptophan in the treatment of anxiety disorders. J
Affect Disorder 8(2):197-200, 1985.
Benjamin J, Agam G, Levine J, et al. Inositol treatment in psychiatry. Psychopharmacol Bull
31(1):167-75, 1995.
Levine J, Rapaport A, Lev L, et al. Inositol treatment raises CSF inositol levels. Brain Res 627(1):168-70, 1993.
Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 152(7):1084-6, 1995.
Pfeiffer, Carl. Mental and Elemental Nutrients. New Canaan, CT, Keats Publishing Company, 1975.
Mills DE, Prkachin KM, Harvey KA, Ward RP. Dietary fatty acid supplementation alters stress reactivity and performance in man. J Hum Hypertens 3:111-16, 1989.
Mills DE, Ward RP. Effects of eicosapentaenoic acid (20:5 omega 3) on stress reactivity in rats.
Proc Soc Exp Biol Med 182(1):127-31, 1986.
Hoes MJ. Monamines in psychiatry: the role of serotonin in depression, anxiety and stress. Acta Psychiatr Belg 82(3):287-309, 1982.
Hoyse SE. Experiences with L-tryptophan in a child and family psychiatric
department. J Int Med Res 10(3):157-9, 1982.
Replogle WH, Eicke FJ. Megavitamin therapy in the reduction of anxiety and
depression among alcoholics. J Orthomol Med 4(4):221-4, 1989.
King DS. Can allergic exposure provoke psychological symptoms? A double-blind test. Biol Psychiatry 16(1):3-19, 1981.
Salzer HM. Relative hypoglycemia as a cause of neuropsychiatric illness. J Natl Med
Assoc 58(1):12-17, 1966.
N.R. Farnsworth et al., "Siberian Ginseng (Eleutherococcus senticosus): Current Status as an Adaptogen", Economic Medical Plant Research 1 (1985): 156-215.
H. Hikino, "Traditional Remedies and Modern Assesment: The Case of Ginseng" in R.O.B. Wijeskera, ed., The Medicinal Plant Industry (Boca Raton, FL: CRC Press, 1991): 149-66.
